KK
EW icon

KLP Kapitalforvaltning’s Edwards Lifesciences EW Stock Holding History

KLP Kapitalforvaltning’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.7M Buy
305,922
+2,700
+0.9% +$226K 0.09% 213
2026
Q1 		$24.3M Buy
303,222
+7,900
+3% +$651K 0.1% 203
2025
Q4 		$25.2M Sell
295,322
-10,900
-4% -$895K 0.1% 190
2025
Q3 		$23.8M Buy
306,222
+14,600
+5% +$1.14M 0.09% 206
2025
Q2 		$22.8M Buy
291,622
+77,400
+36% +$5.77M 0.1% 201
2025
Q1 		$15.5M Sell
214,222
-7,800
-4% -$558K 0.08% 264
2024
Q4 		$16.4M Buy
+222,022
New +$15.5M 0.08% 251

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

KLP Kapitalforvaltning's EW Position: Q2 2026 in Review

KLP Kapitalforvaltning increased its Edwards Lifesciences (EW) stake by 0.89% in Q2 2026, buying an estimated $226K and bringing the position to 305,922 shares worth $27.7M. The position accounts for 0.09% of the portfolio, ranked #213.

KLP Kapitalforvaltning first reported a position in EW in Q4 2024 and has held it in 7 quarters since. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • KLP Kapitalforvaltning held 305,922 shares of Edwards Lifesciences worth $27.7M as of Q2 2026.
  • KLP Kapitalforvaltning bought 2,700 Edwards Lifesciences shares in Q2 2026, an estimated $226K.
  • Edwards Lifesciences made up 0.09% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #213 holding.
  • KLP Kapitalforvaltning first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 7 quarters since.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.